These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 2650063

  • 61. Manipulation of T-cell responses with monoclonal antibodies.
    Waldmann H.
    Annu Rev Immunol; 1989; 7():407-44. PubMed ID: 2469440
    [No Abstract] [Full Text] [Related]

  • 62. Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy.
    Trager DK, Banks BA, Rosenbaum GE, Holm BI, Shizuru JA, Strober S, Fathman CG.
    Transplantation; 1989 Apr; 47(4):587-91. PubMed ID: 2523098
    [Abstract] [Full Text] [Related]

  • 63. Impact of sairei-to and its individual constituents on cardiac allograft survival.
    Zhang Q, Jin X, Uchiyama M, Yakubo S, Niimi M.
    J Heart Lung Transplant; 2010 Jul; 29(7):818-20. PubMed ID: 20382036
    [No Abstract] [Full Text] [Related]

  • 64. [Changes in the activity of lymphocyte dehydrogenases in heart recipients as a possible indicator of reaction of transplant rejection].
    Frolova MA, Bol'shukhina LA, Gudkova RG, Fal'kovskiĭ GE.
    Eksp Khir Anesteziol; 1975 Jul; (2):54-7. PubMed ID: 1102288
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Of mice and men. How form affects function in monoclonal-antibody drugs.
    Erickson D.
    Sci Am; 1990 Apr; 262(4):76-7. PubMed ID: 2315680
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Fetal liver cell transplantation: survival of grafted BALB/c lysosomal storage disease mice.
    Veyron P, Touraine JL.
    Transplant Proc; 1990 Oct; 22(5):2253-4. PubMed ID: 2219360
    [No Abstract] [Full Text] [Related]

  • 70. Bioreagents in allograft immunosuppression.
    Soulillou JP.
    Adv Nephrol Necker Hosp; 1992 Oct; 21():373-86. PubMed ID: 1373557
    [No Abstract] [Full Text] [Related]

  • 71. Transplantation of the mouse heart--a useful research model.
    Jirsch DW, Kraft N, Diener E.
    Cardiovasc Res; 1974 Jan; 8(1):145-8. PubMed ID: 4150497
    [No Abstract] [Full Text] [Related]

  • 72. Acute rejection of the heart-lung allograft and methods of its detection.
    Griffith BP, Durham SJ, Hardesty RL, Trento A, Paradis IL.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2527-30. PubMed ID: 3103298
    [No Abstract] [Full Text] [Related]

  • 73. In vivo suppression of allograft rejection by cyclic AMP increasing agents.
    Ljungström I, Holmgren J.
    Int Arch Allergy Appl Immunol; 1979 Feb; 58(1):99-104. PubMed ID: 217841
    [Abstract] [Full Text] [Related]

  • 74. Immunosuppression with monoclonal antibodies--rules for effective serotherapy.
    Cobbold SP, Martin G, Lovat PE, Waldmann H.
    Adv Exp Med Biol; 1985 Feb; 186():789-95. PubMed ID: 3876725
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Treatment with monoclonal anti-IL2 antibody prolongs cardiac allograft survival in rats.
    Ohnishi T, Sakagami K, Orita K.
    Transplant Proc; 1987 Oct; 19(5):4304-7. PubMed ID: 3314033
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Immunosuppressive effects of an interferon preparation in vivo.
    Hirsch MS, Ellis DA, Black PH, Monaco AP, Wood ML.
    Transplantation; 1974 Feb; 17(2):234-6. PubMed ID: 4590293
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.